Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,476
in 2 filings

Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBIN HOWARD W −$30K President & CEO sold <1% of stake
  2. Zalevsky Jonathan −$13K Chief R&D Officer sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-19 Labrucherie Gil M SVP, COO & CFO Sale −2,000 $22.62 $45K 245,494
2020-05-18 Zalevsky Jonathan Chief R&D Officer Sale −4,558 $22.51 $103K 322,515
2020-05-18 Wilson Mark Andrew SVP & General Counsel Sale −1,529 $22.51 $34K 52,418
2020-05-18 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −1,367 $22.51 $31K 172,719
2020-05-18 ROBIN HOWARD W President & CEO Sale −8,968 $22.51 $202K 375,903
2020-05-18 Labrucherie Gil M SVP, COO & CFO Sale −5,727 $22.51 $129K 247,494
2020-04-15 CHESS ROBERT Director Option exercise −8,000 $9.24 $74K 284,973
2020-04-15 CHESS ROBERT Director Sale −7,803 $18.36 $143K 277,170
2020-04-15 CHESS ROBERT Director Sale −197 $19.02 $4K 276,973
2020-04-15 CHESS ROBERT Director Option exercise · Stock Option −8,000 16,000
2020-03-11 CHESS ROBERT Director Option exercise −8,000 $9.24 $74K 284,973
2020-03-11 CHESS ROBERT Director Sale −6,800 $16.68 $113K 278,173
2020-03-11 CHESS ROBERT Director Sale −1,200 $17.41 $21K 276,973
2020-03-11 CHESS ROBERT Director Option exercise · Stock Option −8,000 24,000
2020-02-18 Zalevsky Jonathan Chief R&D Officer Sale −4,774 $22.35 $107K 327,073
2020-02-18 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −1,394 $22.35 $31K 174,086
2020-02-18 ROBIN HOWARD W President & CEO Sale −8,448 $22.35 $189K 384,871
2020-02-18 Labrucherie Gil M SVP, COO & CFO Sale −5,938 $22.35 $133K 253,221
2020-02-12 CHESS ROBERT Director Option exercise −8,000 $9.24 $74K 284,973
2020-02-12 CHESS ROBERT Director Sale −4,401 $23.32 $103K 280,572

Page 20 of 29 · 562 trades